Original Article

Improving Fecal Immunochemical Testing Rates for Colon Cancer Screening in the Outpatient Setting

Authors: We’am Hussain, MD, William Aurand, DO, Nneoma Onuorah, MBBS, Gabrielle Krstevski, DO, Ronald Markert, PhD, Kerianne Springer, MD, Sangeeta Agrawal, MD

Abstract

Objectives: The amount of colorectal cancer (CRC) screening using the noninvasive fecal immunochemical test (FIT) at a federally qualified health center, Five Rivers Health Clinic (Dayton, Ohio), has been low historically. Our quality improvement (QI) project aimed to improve CRC screening adherence in eligible patients who opted for FIT.

Methods: Three hundred ninety-two patients with FIT orders for CRC were screened during an 11-month period. The preintervention group (pre-I) was enrolled from December 1, 2018 to May 31, 2019, and the postintervention group (post-I) from June 1, 2019 to October 31, 2019. Three interventions were used: resident physicians trained during clinic meetings regarding FIT education for patients, posters displayed in patient rooms outlining the benefits of CRC screening, and standardized US mail reminder letters sent to FIT patients. Patient demographics and clinical variables were collected along with return rate.

Results: The return rate for post-I was twice that of pre-I (74.4%, 95% confidence interval 64.6–82.3 vs 31.1, 95% confidence interval 26.2–36.6; P < 0.001). The pre-I/post-I groups did not differ on demographic and clinical characteristics, and, except for race, none of these variables was associated with returning the FIT screening card.

Conclusions: The compliance rate for FIT completion and return more than doubled among our clinic patients after using a three-component QI intervention. Except for a difference in race, the lack of association between demographic and clinical characteristics with either pre-I/post-I group or return/no return of the FIT card leads us to conclude that our QI program for increasing FIT compliance is effective. Other settings where CRC screening is a prominent component of preventive care may benefit from adopting a similar QI intervention.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. US Preventive Services Task Force. Final recommendation statement. Colorectal cancer: screening. https://www.uspreventiveservicestaskforce.org/Page/Document/ UpdateSummaryFinal/colorectal-cancer-screening2. Published June 15, 2016. Accessed November 28, 2020.
2. Inadomi JM. Screening for colorectal neoplasia. N Engl J Med 2017;376:149-156.
3. Coury J, Schneider JL, Rivelli JS, et al. Applying the plan-do-study-act (PDSA) approach to a large pragmatic study involving safety net clinics. BMC Health Serv Res 2017;17:411.
4. Reed JE, McNicholas C, Woodcock T, et al. Designing quality improvement initiatives: the action effect method, a structured approach to identifying and articulating programme theory. BMJ Qual Saf 2014;23:1040–1048.
5. Bakhai S, Ahluwalia G, Nallapeta N, et al. Faecal immunochemical testing implementation to increase colorectal cancer screening in primary care. BMJ Open Qual 2018;7:e000400.
6. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 2014;160:171.
7. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89:1406–1422.
8. Stokamer CL, Tenner CT, Chaudhuri J, et al. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med 2005;20:278–282.
9. Denberg TD, Coombes JM, Byers TE, et al. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Ann Intern Med 2006;145:895–900. 10. Thompson RS, Michnich ME, Gray J, et al. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med Care 1986;24:904–914. 11. Myers RE, Ross EA, Wolf TA, et al. Behavioral interventions to increase adherence in colorectal cancer screening. Med Care 1991;29:1039–1050. 12. Ioannou G, Chapko M, Dominitiz J. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003;98:2082–2091.